Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/17/2008EP1968958A1 Substituted thiazoles and their use for producing drugs
09/17/2008EP1968957A1 Substituted thiazoles and their use for producing drugs
09/17/2008EP1968956A2 Calcium channel antagonists
09/17/2008EP1968954A1 Macrocyclic compounds useful as bace inhibitors
09/17/2008EP1968953A2 Method for isolating (r)-tofisopam
09/17/2008EP1968951A1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4.
09/17/2008EP1968950A1 Pyrimidine kinase inhibitors
09/17/2008EP1968948A2 Novel hydrogen sulfate salt
09/17/2008EP1968947A1 Gaba-b receptor modulators
09/17/2008EP1968946A1 Imidazoles as gaba-b receptor modulators
09/17/2008EP1968945A2 Muscarinic receptor antagonists
09/17/2008EP1968944A1 Alkylsulphonamide quinolines
09/17/2008EP1968941A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp)
09/17/2008EP1968940A1 3 , 5-substitued piperidine compounds as renin inhibitors
09/17/2008EP1968938A1 Substituted propiolic acid amides and their use for producing drugs
09/17/2008EP1968937A1 Deazapurine analogs of 1'-aza-l-nucleosides
09/17/2008EP1968705A1 Pharmaceutical combination of a pde-5 inhibitor and a 5-alpha reductase inhibitor
09/17/2008EP1968643A2 Cell penetrating peptide conjugates for delivering of nucleic acids into a cell
09/17/2008EP1968628A2 Transferrin and transferrin-based compositions for diabetes treatment
09/17/2008EP1968627A2 Compositions for disrupting and inhibiting reconstitution of wound biofilm
09/17/2008EP1968617A2 Biocompatible tissue sealants and adhesives
09/17/2008EP1968616A2 Derivatives of sulindac, use thereof and preparation thereof
09/17/2008EP1968615A1 Nitric oxide-releasing polymers
09/17/2008EP1968614A2 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
09/17/2008EP1968613A1 Chitosan-based particles
09/17/2008EP1968612A2 Nucleotide and oligonucleotide prodrugs
09/17/2008EP1968611A2 Transdermal delivery means of a diuretic agent and/or cardiac glycoside agent
09/17/2008EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds
09/17/2008EP1968608A2 Practical, cost-effective synthesis of ubiquinones
09/17/2008EP1968607A1 Treatment of cancer and other diseases
09/17/2008EP1968606A2 Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid
09/17/2008EP1968605A1 Emulsions comprising non-esterified phytosterols in the aqueous phase
09/17/2008EP1968604A2 Crystalline lestaurtinib hydrates and crystalline lestaurtinib hemihydrate hemiacetonitrileate and crystalline lestaurtinib hemihydrate hemitetrahydrofuranate
09/17/2008EP1968603A2 Therapeutic amine-arylsulfonamide conjugate compounds
09/17/2008EP1968602A1 Treatment of barrett's esophagus
09/17/2008EP1968601A2 Salts of potassium atp channel openers and uses thereof
09/17/2008EP1968599A2 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or free fatty acid flux
09/17/2008EP1968598A1 Pyrimidine-2,4-diamines and their uses
09/17/2008EP1968597A1 Compositions and methods for inducing neuronal differentiation
09/17/2008EP1968596A2 Calcium channel antagonists
09/17/2008EP1968595A2 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
09/17/2008EP1968594A2 Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
09/17/2008EP1968593A2 Pharmaceutical composition comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
09/17/2008EP1968592A2 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases
09/17/2008EP1968591A2 Treatment of synucleinopathies
09/17/2008EP1968590A2 Novel compounds
09/17/2008EP1968589A2 Combinations comprising sorafenib and interferon for the treatment of cancer
09/17/2008EP1968588A2 Crystalline forms of dolasetron base and processes for preparation thereof
09/17/2008EP1968587A1 Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods
09/17/2008EP1968585A2 Veterinarian composition to control helminthes in bovines, swines, caprines, equines, ovines, canines and felines
09/17/2008EP1968583A2 Compounds, screens, and methods of treatment
09/17/2008EP1968582A2 Treatment for cutaneous t cell lymphoma
09/17/2008EP1968581A2 Tetracyclic kinase inhibitors
09/17/2008EP1968580A2 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
09/17/2008EP1968579A1 Pharmaceutical compounds
09/17/2008EP1968577A2 Targeting gli proteins in human cancer by small molecules
09/17/2008EP1968576A1 Mif inhibitors
09/17/2008EP1968575A2 Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids
09/17/2008EP1968574A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
09/17/2008EP1968573A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
09/17/2008EP1968572A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
09/17/2008EP1968571A2 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
09/17/2008EP1968570A2 Isoflavones for treating mucopolysaccharidoses
09/17/2008EP1968569A1 Benzopyranone derivatives and their use as anti-coronaviral agents
09/17/2008EP1968568A2 INHIBITORS OF Akt ACTIVITY
09/17/2008EP1968567A1 Omega 3 fatty acid formulations
09/17/2008EP1968566A1 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
09/17/2008EP1968564A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
09/17/2008EP1968563A2 Treatment methods using triaryl methane compounds
09/17/2008EP1968562A2 Multilayer tablet
09/17/2008EP1968561A2 Treatment of renal disorders, diabetic nephropathy and dyslipidemias
09/17/2008EP1968560A1 Antimicrobial composition containing triclosan and at least one functionalized hydrocarbon
09/17/2008EP1968559A2 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
09/17/2008EP1968554A2 Bioadhesive drug formulations for oral transmucosal delivery
09/17/2008EP1968552A1 Pack
09/17/2008EP1968551A2 Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
09/17/2008EP1968548A2 Mometasone compositions and methods of making and using the same
09/17/2008EP1968545A2 Medicament for topical use
09/17/2008EP1968544A2 Drug delivery system for bioadhesion to a vulvovaginal surface
09/17/2008EP1968543A2 Composition and method of use thereof
09/17/2008EP1968539A2 Abuse resistant transmucosal drug delivery device
09/17/2008EP1968499A1 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
09/17/2008EP1968498A2 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
09/17/2008EP1968402A2 Salts of fatty acids and methods of making and using thereof
09/17/2008EP1968383A2 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use
09/17/2008EP1896042A4 Methods and reagents for the treatment of inflammatory disorders
09/17/2008EP1890687B1 Stable pharmaceutical gel of diclofenac sodium
09/17/2008EP1802274B1 Use of cannabidiol for the inhibition of brain tumour cell migration
09/17/2008EP1796668B1 Aqueous pharmaceutical preparation comprising roflumilast
09/17/2008EP1776356B1 Alkyl-and piperidine-substituted benzimidazole-derivates
09/17/2008EP1732892B1 Tetrahydrocarbazoles and derivatives
09/17/2008EP1638978A4 7-substituted camptothecin and camptothecin analogs and methods for preparing same
09/17/2008EP1604991B1 Antitumor effect potentiator and antitumor agent
09/17/2008EP1597239B1 Polymorph of {6,7-bis(2-methoxy-ethoxy)-quinazolin-4-yl}-(3e)
09/17/2008EP1539128B1 Use of skin-protecting substances
09/17/2008EP1503733B1 Oleaginous oral antiparasitic compositions
09/17/2008EP1495003B1 Fredericamycin derivatives
09/17/2008EP1490067B1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/17/2008EP1476563B1 Method for the recombination of genetic elements
09/17/2008EP1465640B1 Use of polysaccharide derivatives as anti-infective substances
1 ... 3083 3084 3085 3086 3087 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 3098 3099 3100 3101 3102 3103 ... 7860